US reportedly in talks with Pfizer to get more COVID-19 vaccine before June

The U.S. government is reportedly negotiating a deal to use its buying power to free up supplies of raw materials to help Pfizer boost production of its COVID-19 vaccine, people familiar with the matter told The New York Times

Advertisement

Pfizer has told the U.S. it can’t commit to sending any more doses than the 100 million it agreed to last summer before June 2021 because it has already committed all of its doses to other countries. But it has indicated that it would be able to make more doses if the U.S. helps by ordering the supplies needed to make them, the Times reported. 

The U.S. and Pfizer are now reportedly negotiating a contract that would allow Pfizer to provide tens of millions more doses of its vaccine to Americans between April and the end of June. 

The government has also been asking if Pfizer could team up with another drugmaker, such as Merck, to help boost its production, the Times reported. 

Read the full article here

More articles on COVID-19 vaccines:
US buys 100M more doses of Moderna vaccine
Cardinal Health to distribute COVID-19 vaccines in Ohio
‘Hope on the horizon’: Dr. Maggie Hagan discusses first days of vaccination at Ascension Via Christi

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.